Approval · Notice of Compliance 11036 · 2009
LUVERIS: Notice of Compliance 11036
Issued December 17, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11036
- Date
- December 17, 2009
- Company
- Emd Serono Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation and product monograph update
- Therapeutic class
- Gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUVERIS | 02339757 | Cancelled Pre Market |
Medicinal ingredients
- LUTROPIN ALFA 22.5 MCG per CART